ArticlePharmaceutics2022

Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-mPD-1 Strain in Melanoma Mice via Combining the Oncolytic Therapy and Immunotherapy.

De-Xi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.